![Sean MacDonald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sean MacDonald
Direttore/Membro del Consiglio presso EDESA BIOTECH, INC.
Patrimonio netto: 8 889 $ in data 31/05/2024
Posizioni attive di Sean MacDonald
Società | Posizione | Inizio | Fine |
---|---|---|---|
EDESA BIOTECH, INC. | Direttore/Membro del Consiglio | 01/05/2023 | - |
Independent Dir/Board Member | 07/06/2019 | - | |
Presidente | 07/06/2019 | 01/05/2023 | |
Bioneer A/S
![]() Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Vendite & Marketing | - | - |
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Amministratore Delegato | 17/04/2024 | - |
Storia della carriera di Sean MacDonald
Precedenti posizioni note di Sean MacDonald
Società | Posizione | Inizio | Fine |
---|---|---|---|
iOnctura SA
![]() iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Corporate Officer/Principal | 01/08/2021 | 01/04/2022 |
Corbin Therapeutics, Inc.
![]() Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform. | Amministratore Delegato | 01/10/2018 | 01/08/2021 |
COSMO PHARMACEUTICALS N.V. | Corporate Officer/Principal | 01/04/2019 | 01/08/2021 |
Edesa Biotech Research, Inc. | Direttore/Membro del Consiglio | 01/09/2017 | 01/06/2019 |
Pharmascience, Inc.
![]() Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Corporate Officer/Principal | 01/10/2012 | 01/10/2018 |
Edesa Biotech, Inc. (Old)
![]() Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Direttore/Membro del Consiglio | - | - |
░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Sean MacDonald
University of Ottawa | Masters Business Admin |
Statistiche
Distribuzione geografica
Canada | 7 |
Danimarca | 2 |
Belgio | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Settori
Health Technology | 8 |
Consumer Services | 2 |
Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
EDESA BIOTECH, INC. | Health Technology |
COSMO PHARMACEUTICALS N.V. | Health Technology |
Aziende private | 8 |
---|---|
Bioneer A/S
![]() Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Health Technology |
Ablynx NV
![]() Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
Edesa Biotech, Inc. (Old)
![]() Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
Corbin Therapeutics, Inc.
![]() Corbin Therapeutics, Inc. Internet Software/ServicesTechnology Services Corbin Therapeutics, Inc. operates as a biotechnology platform. | Technology Services |
Pharmascience, Inc.
![]() Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Pharmascience, Inc. manufactures and distributes generic and drug products. It offers liquids, tablets, capsules, suppositories, powders, and ophthalmic. The company was founded by Morris Goodman and Ted S. Wise in 1983 and is headquartered in Montr?al, Canada. | Health Technology |
iOnctura SA
![]() iOnctura SA Miscellaneous Commercial ServicesCommercial Services iOnctura SA is a pre-clinical stage biopharmaceutical company focused on the research and development of novel immuno-oncology therapeutics for patients fighting cancer. The company was founded in June 2017 and is headquartered in Geneve, Switzerland. | Commercial Services |
Edesa Biotech Research, Inc. | |
Domain Therapeutics SA
![]() Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
- Borsa valori
- Insiders
- Sean MacDonald
- Esperienza